MARILYN VELEZ: Open Payments
NPI 1861877839 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,036 in 88 payments from 28 companies in 2025. Trend: 2023 $1,432 · 2024 $838 · 2025 $2,036
Food & beverage: $2,036
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $262 |
| Amgen Inc. | 9 | $199 |
| CeQur Corporation | 1 | $141 |
| SANOFI-AVENTIS U.S. LLC | 5 | $126 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $122 |
| Ascendis Pharma Endocrinology Inc | 5 | $113 |
| Dexcom, Inc. | 4 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| Lilly USA, LLC | 5 | $88 |
| Xeris Pharmaceuticals, Inc. | 4 | $83 |
Products named: Ozempic, CeQur Simplicity, JARDIANCE, TZIELD, ISTURISA, TEPEZZA, Yorvipath, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
